MarketPulse

regulatory violation

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ImmunityBio Faces Class Action Over FDA Warning on Cancer Drug Claims

ImmunityBio (IBRX) shares plunged 21% after FDA warning letter citing misleading efficacy claims about immunotherapy drug Anktiva. Class action lawsuit underway with May 26 deadline.
IBRXinvestor lossessecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

IBRX Stock Crashes 21% After FDA Warning on Unsupported Cancer Claims

ImmunityBio faces securities lawsuit after FDA warns of misleading Anktiva efficacy claims. Stock plunges 21%, erasing $2B in market value.
IBRXstock declinesecurities class action
BenzingaBenzinga··Lekha Gupta

Chevron Settles $1M Clean Fuel Credits Penalty Over Double-Counting Violations

Chevron settles DOJ renewable fuel credits violation, paying $1 million penalty and retiring $3.6 million in invalidly generated credits from 2022 double-counting scheme.
CVXFDLHDVNANRsettlementrenewable fuel credits